학력

• 2015.02

  인하대학교 의학과 박사

• 2010.08

  인하대학교 의학과 석사

• 2006.02

  건국대학교 의학과 학사

주요경력

• 2021.03 ~ 현재

  인하대학교병원 진단검사의학과 조교수

• 2019.03 ~ 2021.02

  인하대학교병원 진단검사의학과 임상조교수

• 2017.03 ~ 2019.02

  가톨릭대학교 서울성모병원 진단검사의학과 임상조교수

• 2016.03 ~ 2017.02

  가톨릭대학교 서울성모병원 진단검사의학과 임상조교수대우

• 2012.03 ~ 2015.02

  가톨릭대학교 서울성모병원 진단검사의학과 임상강사

• 2008.03 ~ 2012.02

  인하대학교병원 진단검사의학과 전공의

• 2006.03 ~ 2007.02

  건국대학교병원 인턴

학회활동

• -

  대한진단검사의학회 정회원

• -

  대한진단혈액학회 정회원

• -

  대한진단유전학회 정회원

수상경력

• 2018.01

  대한진단검사의학회 우수연제상 (2018)

• 2017.01

  대한진단혈액학회 우수논문상 (2017)

• 2015.01

  대한혈액학회 춘계학술대회 우수연제상 (2015)

주요 논문 및 저서

• 2019

  CDKN2B downregulation and other genetic characteristics in T-acute lymphoblastic leukemia. Jang W, Park J, Kwon A, Choi H, Kim J, Lee GD, Han E, Jekarl DW, Chae H, Han K, Yoon JH, Lee S, Chung NG, Cho B, Kim M, Kim Y. Exp Mol Med. 2019 Jan 11;51(1):4.

• 2019

  Chromosomal Microarray Analysis as a First-Tier Clinical Diagnostic Test in Patients With Developmental Delay/Intellectual Disability, Autism Spectrum Disorders, and Multiple Congenital Anomalies: A Prospective Multicenter Study in Korea. Jang W, Kim Y, Han E, Park J, Chae H, Kwon A, Choi H, Kim J, Son JO, Lee SJ, Hong BY, Jang DH, Han JY, Lee JH, Kim SY, Lee IG, Sung IK, Moon Y, Kim M, Park JH. Ann Lab Med. 2019 May;39(3):299-310.

• 2018

  Hereditary dehydrated stomatocytosis with splicing site mutation of PIEZO1 mimicking myelodysplastic syndrome diagnosed by targeted next-generation sequencing. Park J, Jang W, Han E, Chae H, Yoo J, Kim Y, Kim YJ, Kim M. Pediatr Blood Cancer. 2018 Jul;65(7):e27053.

• 2017

  Considerations when using next-generation sequencing for genetic diagnosis of long-QT syndrome in the clinical testing laboratory. Chae H, Kim J, Lee GD, Jang W, Park J, Jekarl DW, Oh YS, Kim M, Kim Y. Clin Chim Acta. 2017 Jan;464:128-135.

• 2016

  Significance of KIT exon 17 mutation depends on mutant level rather than positivity in core-binding factor acute myeloid leukemia. Jang W, Yoon JH, Park J, Lee GD, Kim J, Kwon A, Choi H, Han K, Nahm CH, Kim HJ, Min WS, Kim M, Kim Y. Blood Cancer J. 2016 Jan 15;6:e387.

• 2016

  Extranasal natural killer/T-cell lymphoma initially presenting as myelofibrosis. Jang W, Kim M. Blood Res. 2016 Mar;51(1):7.

• 2016

  A twin sibling with Prader-Willi syndrome caused by type 2 microdeletion following assisted reproductive technology: A case report. Han JY, Park J, Jang W, Chae H, Kim M, Kim Y. Biomed Rep. 2016 Jul;5(1):18-22.

• 2016

  Identification of small marker chromosomes using microarray comparative genomic hybridization and multicolor fluorescent in situ hybridization. Jang W, Chae H, Kim J, Son JO, Kim SC, Koo BK, Kim M, Kim Y, Park IY, Sung IK. Mol Cytogenet. 2016 Aug 8;9:61.

• 2014

  Acute myeloid leukemia of mixed megakaryocytic and erythroid origin following chemotherapy for T-cell lymphoblastic lymphoma. Jang W, Kim M, Lee JW, Chung NG. Int J Hematol. 2014 Mar;99(3):213-4.

• 2013

  Evaluation of MicroScan WalkAway and Vitek 2 for determination of the susceptibility of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates to cefepime, cefotaxime and ceftazidime. Jang W, Park YJ, Park KG, Yu J. J Antimicrob Chemother. 2013 Oct;68(10):2282-5.